K. Bowker

发表

Bacterial strike-through of re-usable surgical drapes: the effect of different wetting agents.

A. Blom, C. Gozzard, J. Heal, 2002, The Journal of hospital infection.

Clinical diagnosis and treatment of common respiratory tract infections in relation to microbiological profiles in rural health facilities in China: implications for antibiotic stewardship

K. Bowker, A. MacGowan, Ya-ping Pan, 2021, BMC Family Practice.

Pathways to optimising antibiotic use in rural China: identifying key determinants in community and clinical settings, a mixed methods study protocol

K. Bowker, A. MacGowan, M. Hickman, 2019, BMJ Open.

Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection.

K. Bowker, A. MacGowan, W. Alfouzan, 2017, International journal of antimicrobial agents.

Typing of Listeria monocytogenes by random amplified polymorphic DNA (RAPD) analysis.

K. Bowker, J. McLauchlin, K. O'Donoghue, 1995, International journal of food microbiology.

Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis.

K. Bowker, M. Cobb, M. A. Cobb, 2005, Veterinary journal.

Theatre shoes - a link in the common pathway of postoperative wound infection?

K. Bowker, A. Blom, R. Amirfeyz, 2007, Annals of the Royal College of Surgeons of England.

Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.

K. Bowker, A. MacGowan, J. Sunderland, 1998, The Journal of antimicrobial chemotherapy.

In vitro models, in vivo models, and pharmacokinetics: what can we learn from in vitro models?

K. Bowker, A. MacGowan, C. Rogers, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A critical assessment of the agar dilution chequerboard technique for studying in-vitro antimicrobial interactions using a representative beta-lactam, aminoglycoside and fluoroquinolone.

K. Bowker, A. MacGowan, M. Wootton, 1995, The Journal of antimicrobial chemotherapy.

In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics.

K. Bowker, M. Wootton, D. Reeves, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans.

K. Bowker, A. MacGowan, D. Reeves, 1998, Journal of Antimicrobial Chemotherapy.

The occurrence and seasonal changes in the isolation of Listeria spp. in shop bought food stuffs, human faeces, sewage and soil from urban sources.

K. Bowker, J. McLauchlin, A. Macgowan, 1994, International journal of food microbiology.

Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia

K. Bowker, A. MacGowan, A. Macgowan, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci.

K. Bowker, A. MacGowan, M. Wootton, 1999, The Journal of antimicrobial chemotherapy.

Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis.

K. Bowker, A. MacGowan, J. Harvey, 2000, The Journal of antimicrobial chemotherapy.

Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, C. Rogers, 2003, Antimicrobial Agents and Chemotherapy.

Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria.

K. Bowker, A. MacGowan, M. Wootton, 1997, The Journal of antimicrobial chemotherapy.

Prevalence of antibiotic resistance in Escherichia coli isolated from urine samples routinely referred by general practitioners in a large urban centre in south-west England.

C. Mcnulty, K. Bowker, A. MacGowan, 2015, The Journal of antimicrobial chemotherapy.

Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms.

K. Bowker, J. Greenman, S. Nelson, 2005, The Journal of antimicrobial chemotherapy.

Should finger rings be removed prior to scrubbing for theatre?

G. Bannister, K. Bowker, N. K. R. Kelsall, 2006, The Journal of hospital infection.

The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infection.

K. Bowker, A. MacGowan, A. Noel, 2020, International journal of antimicrobial agents.

An in vitro biofilm model of Staphylococcus aureus infection of bone

K. Bowker, A. MacGowan, S. Nelson, 2019, Letters in applied microbiology.

The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against &bgr;-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection

K. Bowker, A. MacGowan, A. Noel, 2016, The Journal of antimicrobial chemotherapy.

Comparative antibacterial effects of moxifloxacin and levofloxacin on Streptococcus pneumoniae strains with defined mechanisms of resistance: impact of bacterial inoculum.

K. Bowker, A. MacGowan, A. Noel, 2013, The Journal of antimicrobial chemotherapy.

Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.

K. Bowker, A. MacGowan, A. Noel, 2009, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of Ceftazidime plus the Serine β-Lactamase Inhibitor AM-112 against Escherichia coli Containing TEM-1 and CTX-M-1 β-Lactamases

K. Bowker, A. MacGowan, C. Rogers, 2004, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Ceftazidime plus the Serine (cid:2) -Lactamase Inhibitor AM-112 against Escherichia coli Containing TEM-1 and CTX-M-1 (cid:2) -Lactamases

K. Bowker, A. MacGowan, C. Rogers, 2004 .

Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models.

K. Bowker, A. MacGowan, A. Macgowan, 2002, International journal of antimicrobial agents.

Pharmacodynamics of Telavancin Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, A. Noel, 2010, Antimicrobial Agents and Chemotherapy.

The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments.

K. Bowker, A. MacGowan, A. Noel, 2015, International journal of antimicrobial agents.

Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae

K. Bowker, A. MacGowan, A. Noel, 2012, Antimicrobial Agents and Chemotherapy.

In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patients.

K. Bowker, A. MacGowan, M. Wootton, 2002, The Journal of antimicrobial chemotherapy.

Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory.

K. Bowker, A. MacGowan, J. Sunderland, 2006, International journal of antimicrobial agents.

A comparison of the penetration of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement.

G. Bannister, K. Bowker, A. MacGowan, 1997, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.

K. Bowker, A. MacGowan, A. Noel, 2006, The Journal of antimicrobial chemotherapy.

Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant Genotypes

K. Bowker, A. MacGowan, K. Heesom, 2017, Antimicrobial Agents and Chemotherapy.

Bacterial Strain-to-Strain Variation in Pharmacodynamic Index Magnitude, a Hitherto Unconsidered Factor in Establishing Antibiotic Clinical Breakpoints

K. Bowker, A. MacGowan, R. Reynolds, 2009, Antimicrobial Agents and Chemotherapy.

Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, C. Rogers, 2004, Antimicrobial Agents and Chemotherapy.

Mechanism of Fluoroquinolone Resistance Is an Important Factor in Determining the Antimicrobial Effect of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, A. Macgowan, 2003, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, C. Rogers, 2001, Antimicrobial Agents and Chemotherapy.

Activity of Moxifloxacin, Administered Once a Day, against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model of Infection

K. Bowker, A. MacGowan, M. Wootton, 1999, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Minocycline against Staphylococcus aureus in an In Vitro Pharmacokinetic Model

Alasdair P. MacGowan, K. Bowker, A. MacGowan, 2008, Antimicrobial Agents and Chemotherapy.

A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone.

K. Bowker, A. MacGowan, M. Wootton, 1996, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of Ceftaroline against Staphylococcus aureus Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, A. Noel, 2013, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of the Antibacterial Effect of and Emergence of Resistance to Doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, A. Noel, 2012, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Razupenem (PZ601) Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, A. Noel, 2011, Antimicrobial Agents and Chemotherapy.

Ampicillin-aminoglycoside interaction studies using Listeria monocytogenes.

K. Bowker, A. MacGowan, M. Wootton, 1998, The Journal of antimicrobial chemotherapy.

Continuous Infusion of β-Lactam Antibiotics

K. Bowker, A. MacGowan, Karen E. Bowker, 1998 .

The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens.

K. Bowker, A. MacGowan, C. Rogers, 2000, The Journal of antimicrobial chemotherapy.

Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin.

K. Bowker, A. MacGowan, C. Rogers, 2000, The Journal of antimicrobial chemotherapy.

Comparison of in-vitro pharmacodynamics of once and twice daily ciprofloxacin.

K. Bowker, A. MacGowan, C. Rogers, 1999, The Journal of antimicrobial chemotherapy.

The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model.

K. Bowker, A. MacGowan, P. Bennett, 2001, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection.

K. Bowker, A. MacGowan, K. Krause, 2019, International journal of antimicrobial agents.

Direct measurement of bacterial penetration through surgical gowns: a new method.

G E Bartlett, K E Bowker, G C Bannister, 2002, The Journal of hospital infection.

Comparative evaluation of eight different in vitro pharmacodynamic models of infection. Activity of moxifloxacin against Escherichia coli and Streptococcus pneumoniae as an exemplary example.

K. Bowker, A. MacGowan, A. Dalhoff, 2019, International journal of antimicrobial agents.

The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.

K. Bowker, A. MacGowan, A. Noel, 2021, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of aztreonam against Escherichia coli and Klebsiella oxytoca: defining pharmacodynamic targets.

K. Bowker, A. MacGowan, A. Noel, 2019, The Journal of antimicrobial chemotherapy.

Sequential antimicrobial therapy: pharmacokinetic and pharmacodynamic considerations in sequential therapy.

K. Bowker, A. MacGowan, 1998, The Journal of infection.

Clothing in laminar-flow operating theatres.

G. Bannister, K. Bowker, A. MacGowan, 1996, The Journal of hospital infection.

Storage of equipment above areas used for opening sterile theatre gowns: is there an infection risk?

K. Bowker, A. Pentlow, J. Murray, 2009, The Journal of hospital infection.

Bacterial contamination of surgical gloves by water droplets spilt after scrubbing.

A. Blom, J. Heal, K. Bowker, 2003, The Journal of hospital infection.

Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region

K. Bowker, A. MacGowan, K. Reyher, 2021, bioRxiv.

Comment on: Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.

K. Bowker, A. MacGowan, A. Noel, 2020, Journal of Antimicrobial Chemotherapy.

Antibacterial effect of imipenem/relebactam on aerobic Gram-negative bacilli: in vitro simulations of 7 or 14 day human exposures.

K. Bowker, A. MacGowan, A. Noel, 2019, The Journal of antimicrobial chemotherapy.

Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection

K. Bowker, A. MacGowan, A. Noel, 2018, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of Moxifloxacin against Anaerobes Studied in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, A. Noel, 2005, Antimicrobial Agents and Chemotherapy.

In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii.

K. Bowker, A. MacGowan, A. Noel, 2020, The Journal of antimicrobial chemotherapy.

Dalbavancin Activity Tested Against a Contemporary Collection of Gram-positive Bacteria from Hospitals in the UK and Ireland: Results from DECIDE Program

K. Bowker, M. Cormican, R. Howe, 2008 .

Multicentre study of the in vitro activity of ceftolozane/tazobactam and other commonly used antibiotics against Pseudomonas aeruginosa isolates from patients in the UK

K. Bowker, M. Wootton, I. Monahan, 2020, JAC-antimicrobial resistance.

Colistin susceptibility testing: time for a review.

K. Bowker, A. MacGowan, A. Noel, 2014, The Journal of antimicrobial chemotherapy.

Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures.

K. Bowker, R. Marshall, A. Macgowan, 1997, The Journal of hospital infection.

Synergy testing of macrolide combinations using the chequerboard technique.

K. Bowker, A. MacGowan, D. Reeves, 1993, The Journal of antimicrobial chemotherapy.

Topical ethyl chloride fine spray. Does it have any antimicrobial activity?

K. Bowker, M. Bradley, R. Reynolds, 2006, Clinical Radiology.

Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin.

K. Bowker, A. MacGowan, H. Wiesinger-Mayr, 1999, The Journal of antimicrobial chemotherapy.

Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid

K. Bowker, A. MacGowan, R. Howe, 2003, Antimicrobial Agents and Chemotherapy.

Vancomycin-resistant Staphylococcus aureus

K. Bowker, T. Feest, A. MacGowan, 1998, The Lancet.

BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials.

K. Bowker, A. MacGowan, M. Wootton, 2002, The Journal of antimicrobial chemotherapy.

Headwear in laminar flow operating theatres.

R. J. Gordon, G. Bannister, K. Bowker, 2009, The Journal of hospital infection.

The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria.

K. Bowker, A. MacGowan, M. Wootton, 1996, Journal of Antimicrobial Chemotherapy.

In Vitro Activities of Y-688, a New 7-Substituted Fluoroquinolone, against Anaerobic Bacteria

K. Bowker, A. MacGowan, M. Wootton, 1998, Antimicrobial Agents and Chemotherapy.

The passage of bacteria through surgical drapes.

A. Blom, K. Bowker, C. Estela, 2000, Annals of the Royal College of Surgeons of England.

Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.

K. Bowker, A. MacGowan, M. Avison, 2019, The Journal of antimicrobial chemotherapy.

Characterisation of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-2018

K. Bowker, A. MacGowan, M. Avison, 2019, bioRxiv.

Pharmacodynamics of the Antibacterial Effect and Emergence of Resistance to Tomopenem, Formerly RO4908463/CS-023, in an In Vitro Pharmacokinetic Model of Staphylococcus aureus Infection

K. Bowker, A. MacGowan, A. Noel, 2008, Antimicrobial Agents and Chemotherapy.

Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and G.

K. Bowker, A. MacGowan, M. Wootton, 1999, The Journal of antimicrobial chemotherapy.

Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations.

K. Bowker, A. MacGowan, D. Reeves, 1996, The Journal of antimicrobial chemotherapy.

Vancomycin efficacy (MIC and Bactericidality) in Clinical Outcome in Patients with Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteraemia

K. Bowker, A. MacGowan, A. Lovering, 2008 .

Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia

K. Bowker, A. Macgowan, I. Weir, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Reducing the Risk of Surgical Site Infection: A Case Controlled Study of Contamination of Theatre Clothing

J. Soar, G. Bannister, K. Bowker, 2011, Journal of Perioperative Practice.

Pharmacodynamics of inhaled amikacin (BAY 41-6551) studied in an in vitro pharmacokinetic model of infection

K. Bowker, A. MacGowan, A. Noel, 2018, Journal of Antimicrobial Chemotherapy.

Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.

K. Bowker, A. Noel, M. Attwood, 2022, Journal of Antimicrobial Chemotherapy.

The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model.

K. Bowker, M. Wootton, H. Holt, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Once-a-day carbapenem therapy.

K. Bowker, J. Harvey, D. Reeves, 1996, The Journal of antimicrobial chemotherapy.

Effect of jewellery on surface bacterial counts of operating theatres.

G E Bartlett, T C B Pollard, K E Bowker, 2002, The Journal of hospital infection.

The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins.

K. Bowker, A. Hedges, D. Reeves, 1995, Journal of Antimicrobial Chemotherapy.

In Vitro Activities of Three New Dihydrofolate Reductase Inhibitors against Clinical Isolates of Gram-Positive Bacteria

K. Bowker, P. Caspers, A. Macgowan, 2009, Antimicrobial Agents and Chemotherapy.

Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant Genotypes

K. Bowker, K. Heesom, M. Avison, 2017, Antimicrobial Agents and Chemotherapy.

Prevalence, drivers and surveillance of antibiotic resistance and antibiotic use in rural China: Interdisciplinary study

K. Bowker, J. Chai, X. Hu, 2023, PLOS global public health.

To disinfect or not to disinfect the foot in total joint arthroplasty of the lower limb.

K. Bowker, A. W. Blom, B. Lankaster, 2001, The Journal of hospital infection.

Comparative antibacterial effects of moxifloxacin and levofloxacin on Streptococcus pneumoniae strains with defined mechanisms of resistance: impact of bacterial inoculum.

K. Bowker, A. Noel, S. Tomaselli, 2013, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of Ceftaroline against Staphylococcus aureus Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. Noel, S. Tomaselli, 2013, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Telavancin Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. Noel, S. Tomaselli, 2010, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of the Antibacterial Effect and Emergence of Resistance to Tomopenem, Formerly RO4908463/CS-023, in an In Vitro Pharmacokinetic Model of Staphylococcus aureus Infection

K. Bowker, A. Noel, A. Macgowan, 2008, Antimicrobial Agents and Chemotherapy.

Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in an in vitro pharmacokinetic model of infection.

K. Bowker, A. Noel, S. Tomaselli, 2016, The Journal of antimicrobial chemotherapy.